A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

HELIOS Klinikum Berlin-Buch, Berlin

Charité Campus Virchow-Klinikum, Berlin

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari, Hamburg

Hospital Infantil Universitario Niño Jesús, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario La Fe de Valencia, Valencia

Azienda Ospedaliero Universitaria Meyer, Florence

Asklepios Klinik Sankt Augustin, Sankt Augustin

Hôpital Universitaire Necker Enfants Malades, Paris

Centre Hospitalier Universitaire de Poitiers, Poitiers

Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre

Hospital Sant Joan de Déu, Esplugues de Llobregat

Bristol Royal Hospital for Children, Bristol

Cambridge Clinical Research Facility, Cambridge

Alder Hey Children's Hospital, Liverpool

Royal Victoria Infirmary, Newcastle upon Tyne

University Hospital Southampton NHS Foundation Trust, Southampton

Great Ormond Street Hospital For Children NHS Foundation Trust, London

Sheffield Children's Hospital, Sheffield